Heightened sensitivity to paclitaxel in Class IVa beta-tubulin-transfected cells is lost as expression increases

Hailing Yang1, Fernando Cabral1

  • 1Department of Integrative Biology and Pharmacology, University of Texas Medical School, Houston, Texas 77030.

Insights

Beta4a-tubulin alters microtubule assembly and drug sensitivity. Its expression increases sensitivity to some antimitotic drugs but reduces it to paclitaxel at higher levels, indicating complex interactions.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Microtubules are crucial cytoskeletal components involved in cell division and intracellular transport.
  • Beta-tubulin isotypes play distinct roles in microtubule dynamics and drug responses.
  • Beta4a-tubulin is a neuronal-specific isotype with largely unknown functions.

Purpose of the Study:

  • To investigate the impact of beta4a-tubulin expression on microtubule organization, assembly, and sensitivity to antimitotic drugs.
  • To elucidate the specific amino acid residues responsible for beta4a-tubulin's unique effects.

Main Methods:

  • Stable transfection of Chinese hamster ovary (CHO) cells with varying levels of beta4a-tubulin.
  • Assessment of microtubule assembly dynamics and organization.
  • Drug sensitivity assays using colcemid, vinblastine, nocodazole, and paclitaxel.
  • Site-directed mutagenesis of beta4a and beta4b-tubulin followed by expression in CHO cells.

Main Results:

  • Beta4a-tubulin expression reduced microtubule assembly and increased sensitivity to colcemid, vinblastine, and nocodazole.
  • Paclitaxel sensitivity showed a biphasic response: increased at low beta4a expression, decreased at high expression.
  • Mutations N332S or N335S in beta4b-tubulin mimicked beta4a's effects on microtubule disruption and colcemid sensitivity.
  • Mutation Ala(115) to serine in beta4a-tubulin reversed paclitaxel hypersensitivity, while S115A in beta4b had no effect.

Conclusions:

  • Beta4a-tubulin significantly modulates microtubule dynamics and antimitotic drug responses.
  • The interaction with paclitaxel is complex, involving substoichiometric binding and counteracting disruptive effects at high expression levels.
  • Specific amino acid residues, particularly around position 115 and 332/335, are critical for mediating beta4a-tubulin's distinct functional phenotype.